Nitromist (nitroglycerin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 CONTRAINDICATIONS PDE5 Inhibitor Use Addition to the end of the paragaragh:  Do not use NitroMist in patients who...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts